ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Los Angeles, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Esophageal Cancer
Prostatic Cancer

Adenocarcinoma trials near Los Angeles, CA, USA:

Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma

pembrolizumab in subjects with advanced gastric and gastroesophageal adenocarcinoma. These are subjects who have progressed, or not tolerate...

Active, not recruiting
Gastric Adenocarcinoma
GastroEsophageal Cancer
Drug: Pembrolizumab
Drug: Cabozantinib

Phase 2

University of California Irvine (UCI)
University of California Irvine (UCI)

Orange, California, United States

with chemotherapy and chemoradiation in locally advanced esophageal adenocarcinoma to examine the safety and efficacy of the combination of ...

Active, not recruiting
Esophageal Adenocarcinoma
Drug: Carboplatin
Drug: Pembrolizumab

Phase 2

Weill Cornell Medicine (WCM)
Weill Cornell Medicine (WCM)

Los Angeles, California, United States and 3 other locations

(TPC) in participants with advanced/metastatic gastroesophageal adenocarcinoma. The primary hypothesis of this study is sacituzumab tirumote...

Enrolling
Gastroesophageal Cancer
Drug: Rescue medication
Drug: Supportive care measures

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Los Angeles, California, United States and 101 other locations

The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma...

Enrolling
Advanced Adenocarcinoma
Drug: BA3182

Phase 1

BioAtla

Los Angeles, California, United States and 4 other locations

ductal adenocarcinoma (PDAC). The investigators will evaluate safety and preliminary efficacy of Padeliporfin VTP administered endovascular...

Enrolling
Locally Advanced Unresectable Pancreatic Adenocarcinoma
Combination Product: Padeliporfin Vascular Targeted Photodynamic (VTP) therapy

Phase 1

Impact Biotech

Duarte, California, United States and 1 other location

This study will test the effectiveness (anti-tumor activity), safety, and ability to increase the body's immune system to fight pancreatic cancer by...

Enrolling
Pancreatic Ductal Adenocarcinoma
Resectable Pancreatic Ductal Adenocarcinoma (PDAC)
Drug: Pembrolizumab
Drug: Defactinib

Phase 2

Johns Hopkins Medicine
Johns Hopkins Medicine

Los Angeles, California, United States and 1 other location

to evaluate the safety and efficacy of first-line chemo-immunotherapy combinations in participants with metastatic pancreatic ductal adenocarcinoma...

Active, not recruiting
Metastatic Pancreatic Adenocarcinoma
Drug: NG350A (Cohort C)
Drug: Nab-paclitaxel (nP) (Cohort A, B and C)

Phase 1

Cancer Insight

Los Angeles, California, United States and 5 other locations

determining the efficacy of adjuvant trifluridine and tipiracil (TAS-102) in combination with irinotecan in patients with ctDNA positive colon adenocarcinoma...

Enrolling
Colon Adenocarcinoma
Colorectal Cancer
Diagnostic Test: Signatera MRD ctDNA Assay
Combination Product: Standard Treatment

Phase 1

University of California Irvine (UCI)
University of California Irvine (UCI)

Orange, California, United States

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment.

Enrolling
PDAC - Pancreatic Ductal Adenocarcinoma
PDAC
Drug: 5-fluorouracil
Drug: leucovorin

Phase 3

Revolution Medicines
Revolution Medicines

Los Angeles, California, United States and 4 other locations

42,000-lipase units (capsules), for snacks, are added to standard of care in patients with exocrine pancreatic insufficiency due to pancreatic adenocarcinoma...

Enrolling
Pancreatic Adenocarcinoma
Drug: Pancrelipase

Phase 2

Andrew Hendifar, MD

Los Angeles, California, United States of America

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems